Presentation is loading. Please wait.

Presentation is loading. Please wait.

Sean M. Bagshaw, MD, MS, P. Diane Galbraith, BN, MS, L

Published byKatrine Lotte Hald Modified over 5 years ago

Similar presentations

Presentation on theme: "Sean M. Bagshaw, MD, MS, P. Diane Galbraith, BN, MS, L"— Presentation transcript:

1 Prophylactic Amiodarone for Prevention of Atrial Fibrillation After Cardiac Surgery: A Meta-Analysis 
Sean M. Bagshaw, MD, MS, P. Diane Galbraith, BN, MS, L. Brent Mitchell, MD, Reg Sauve, MD, Derek V. Exner, MD, MPH, William A. Ghali, MD, MPH  The Annals of Thoracic Surgery  Volume 82, Issue 5, Pages (November 2006) DOI: /j.athoracsur Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Flow diagram of study selection process. (AF = atrial fibrillation; RCTs = randomized controlled trials.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Forest plot of fixed-effects model of odds ratios for prevention of post–cardiac surgery atrial fibrillation from 19 randomized controlled trials. (CI = confidence interval.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Cumulative meta-analysis of 19 randomized controlled trials of amiodarone for prevention of post–cardiac surgery atrial fibrillation. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

5 Fig 4 Meta-analysis of secondary outcomes. (A) Forest plot of fixed-effects model for difference in heart rate at onset of atrial fibrillation across 11 studies. (B) Forest plot of random-effects model for difference in hospital length of stay across 11 studies. (C) Forest plot of fixed-effects model for incidence of ventricular tachyarrhythmias across 14 studies. (CI = confidence interval.) (D) Forest plot of fixed-effects model for incidence of transient ischemic attack or stroke across 11 studies. (CI = confidence interval.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

6 Fig 4 Meta-analysis of secondary outcomes. (A) Forest plot of fixed-effects model for difference in heart rate at onset of atrial fibrillation across 11 studies. (B) Forest plot of random-effects model for difference in hospital length of stay across 11 studies. (C) Forest plot of fixed-effects model for incidence of ventricular tachyarrhythmias across 14 studies. (CI = confidence interval.) (D) Forest plot of fixed-effects model for incidence of transient ischemic attack or stroke across 11 studies. (CI = confidence interval.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Sean M. Bagshaw, MD, MS, P. Diane Galbraith, BN, MS, L"

Similar presentations

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.
Surgical Versus Medical Therapy for Prosthetic Valve Endocarditis: A Meta-Analysis of 32 Studies  Christos G. Mihos, DO, Romain Capoulade, PhD, Evin Yucel,

Surgical Versus Medical Therapy for Prosthetic Valve Endocarditis: A Meta-Analysis of 32 Studies  Christos G. Mihos, DO, Romain Capoulade, PhD, Evin Yucel,
Assessment of the Association of Bilateral Internal Thoracic Artery Skeletonization and Sternal Wound Infection After Coronary Artery Bypass Grafting 

Assessment of the Association of Bilateral Internal Thoracic Artery Skeletonization and Sternal Wound Infection After Coronary Artery Bypass Grafting 
Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis  Nathan M. Mollberg, DO,

Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis  Nathan M. Mollberg, DO,
Courtney J. Warner, MD, MS, Spencer W. Greaves, MPH, Robin J

Courtney J. Warner, MD, MS, Spencer W. Greaves, MPH, Robin J
Preoperative Prophylactic Intraaortic Balloon Pump Reduces the Incidence of Postoperative Acute Kidney Injury and Short-Term Death of High-Risk Patients.

Preoperative Prophylactic Intraaortic Balloon Pump Reduces the Incidence of Postoperative Acute Kidney Injury and Short-Term Death of High-Risk Patients.
Endosonography Versus Mediastinoscopy in Mediastinal Staging of Lung Cancer: Systematic Review and Meta-Analysis  Inderpaul Singh Sehgal, MD, DM, Sahajal.

Endosonography Versus Mediastinoscopy in Mediastinal Staging of Lung Cancer: Systematic Review and Meta-Analysis  Inderpaul Singh Sehgal, MD, DM, Sahajal.
The Society of Thoracic Surgeons Lung Cancer Resection Risk Model: Higher Quality Data and Superior Outcomes  Felix G. Fernandez, MD, MS, Andrzej S. Kosinski,

The Society of Thoracic Surgeons Lung Cancer Resection Risk Model: Higher Quality Data and Superior Outcomes  Felix G. Fernandez, MD, MS, Andrzej S. Kosinski,
Robert Brewer, MD, MHSA, Patricia F. Theurer, BSN, Chad M

Robert Brewer, MD, MHSA, Patricia F. Theurer, BSN, Chad M
Lily E. Johnston, MD, MPH, Jennifer L. Kirby, MD, PhD, Emily A

Lily E. Johnston, MD, MPH, Jennifer L. Kirby, MD, PhD, Emily A
Risk-Adjusted Prolonged Length of Stay as an Alternative Outcome Measure for Pediatric Congenital Cardiac Surgery  Ming Liu, MS, MA, Charlotte M. Druschel,

Risk-Adjusted Prolonged Length of Stay as an Alternative Outcome Measure for Pediatric Congenital Cardiac Surgery  Ming Liu, MS, MA, Charlotte M. Druschel,
Postoperative Atrial Fibrillation Prophylaxis After Lung Surgery: Systematic Review and Meta-Analysis  Lars Peter Riber, MD, PhD, Torben Bjerregaard Larsen,

Postoperative Atrial Fibrillation Prophylaxis After Lung Surgery: Systematic Review and Meta-Analysis  Lars Peter Riber, MD, PhD, Torben Bjerregaard Larsen,
Amiodarone after surgical ablation for atrial fibrillation: Is it really necessary? A prospective randomized controlled trial  Niv Ad, MD, Sari D. Holmes,

Amiodarone after surgical ablation for atrial fibrillation: Is it really necessary? A prospective randomized controlled trial  Niv Ad, MD, Sari D. Holmes,
Rajat Kalra, MBChB, Navkaranbir S

Rajat Kalra, MBChB, Navkaranbir S
Mohammed M. Uzzaman, MRCS, MS, J. Daniel Robb, FRCS, MRCP, Peter C. E

Mohammed M. Uzzaman, MRCS, MS, J. Daniel Robb, FRCS, MRCP, Peter C. E
Amiodarone Significantly Decreases Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer  Lars P. Riber, MD, PhD, Thomas D. Christensen,

Amiodarone Significantly Decreases Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer  Lars P. Riber, MD, PhD, Thomas D. Christensen,
Homograft Implantation Techniques in the Aortic Position: To Preserve or Replace the Aortic Root?  Thanos Athanasiou, MD, PhD, Catherine Jones, MBBS,

Homograft Implantation Techniques in the Aortic Position: To Preserve or Replace the Aortic Root?  Thanos Athanasiou, MD, PhD, Catherine Jones, MBBS,
Atrial Fibrillation Correction Surgery: Lessons From The Society of Thoracic Surgeons National Cardiac Database  James S. Gammie, MD, Michel Haddad, MD,

Atrial Fibrillation Correction Surgery: Lessons From The Society of Thoracic Surgeons National Cardiac Database  James S. Gammie, MD, Michel Haddad, MD,
A Randomized Trial Evaluating Amiodarone for Prevention of Atrial Fibrillation After Pulmonary Resection  James E. Tisdale, PharmD, Heather A. Wroblewski,

A Randomized Trial Evaluating Amiodarone for Prevention of Atrial Fibrillation After Pulmonary Resection  James E. Tisdale, PharmD, Heather A. Wroblewski,
Richard C. Cook, MD, MS, Michael H

Richard C. Cook, MD, MS, Michael H

Similar presentations

Ads by Google